Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63. https://doi.org/10.3322/caac.21834.

Article  PubMed  Google Scholar 

Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019;11:287–99. https://doi.org/10.2147/IJWH.S197604.

Article  PubMed  PubMed Central  Google Scholar 

Janciauskiene S, Wrenger S, Günzel S, Gründing AR, Golpon H, Welte T. Potential roles of acute phase proteins in cancer: why do cancer cells produce or take up exogenous acute phase protein alpha1-antitrypsin? Front Oncol. 2021;11: 622076.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Belczacka I, Latosinska A, Metzger J, Marx D, Vlahou A, Mischak H, Frantzi M. Proteomics biomarkers for solid tumors: current status and future prospects. Mass Spectrom Rev. 2019;38(1):49–78. https://doi.org/10.1002/mas.21572.

Article  PubMed  CAS  Google Scholar 

Liao C, An J, Yi S, Tan Z, Wang H, Li H, Guan X, Liu J, Wang Q. FUT8 and protein core fucosylation in tumours: from diagnosis to treatment. J Cancer. 2021;12(13):4109–20. https://doi.org/10.7150/jca.58268.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mroz J, Pelc M, Mitusinska K, Chorostowska-Wynimko J, Jezela-Stanek A. Computational tools to assist in analyzing effects of the SERPINA1 gene variation on alpha-1 antitrypsin (AAT). Genes (Basel). 2024;15(3):340. https://doi.org/10.3390/genes15030340.

Article  PubMed  CAS  Google Scholar 

Grzesik K, Janik M, Hoja-Lukowicz D. The hidden potential of glycomarkers: glycosylation studies in the service of cancer diagnosis and treatment. Biochim Biophys Acta Rev Cancer. 2023;1878(3): 188889. https://doi.org/10.1016/j.bbcan.2023.188889.

Article  PubMed  CAS  Google Scholar 

Tikhonov D, Kulikova L, Kopylov AT, Rudnev V, Stepanov A, Malsagova K, Izotov A, Kulikov D, Zulkarnaev A, Enikeev D, Potoldykova N, Kaysheva AL. Proteomic and molecular dynamic investigations of PTM-induced structural fluctuations in breast and ovarian cancer. Sci Rep. 2021;11(1):19318. https://doi.org/10.1038/s41598-021-98201-7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jaberie H, Hosseini SV, Naghibalhossaini F. Evaluation of alpha 1-antitrypsin for the early diagnosis of colorectal cancer. Pathol Oncol Res. 2020;26(2):1165–73. https://doi.org/10.1007/s12253-019-00679-0.

Article  PubMed  CAS  Google Scholar 

Chen S-Y, Chang T-C, Lin C-Y, Lai C-H, Ren-Chin W, Yang L-Y, Chang W-Y, Lee Y-S, Yang W-CV, Chao A. Serum levels of alpha1-antitrypsin isoforms in patients with ovarian clear cell carcinoma: an exploratory study. J Chinese Med Assoc. 2021;84(11):1048–53. https://doi.org/10.1097/JCMA.0000000000000604.

Article  CAS  Google Scholar 

Li Y-T, Lee W-L, Wang P-H. Is it possible to use the serum levels of alpha 1-antitrypsin as a serum biomarker to distinguish endometriosis and endometriosis-associated epithelial ovarian cancers? J Chinese Med Assoc. 2021;84(11):985–6. https://doi.org/10.1097/JCMA.0000000000000644.

Article  CAS  Google Scholar 

Shrestha B, Dunn L. The declaration of Helsinki on medical research involving human subjects: a review of seventh revision. J Nepal Health Res Council. 2020;17(4):548–52. https://doi.org/10.33314/jnhrc.v17i4.1042.

Article  Google Scholar 

Berek JS, Renz M, Kehoe S, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Int J Gynaecol Obstet. 2021;155(Suppl 1):61–85. https://doi.org/10.1002/ijgo.13878.

Article  PubMed  PubMed Central  Google Scholar 

Pietrowska M, Wlosowicz A, Gawin M, Widlak P. MS-based proteomic analysis of serum and plasma: problem of high abundant components and lights and shadows of albumin removal. Adv Exp Med Biol. 2019;1073:57–76. https://doi.org/10.1007/978-3-030-12298-0_3.

Article  PubMed  CAS  Google Scholar 

Hueso D, Fontecha J, Gómez-Cortés P. Comparative study of the most commonly used methods for total protein determination in milk of different species and their ultrafiltration products. Front Nutr. 2022;9: 925565. https://doi.org/10.3389/fnut.2022.925565.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shabir S, Asiaf A. Comparative study on the mutation spectrum of L-MYC and C-MYC genes of blood cfDNA in patients with ovarian cancer and healthy females. J Obstet Gynaecol Res. 2023;49(12):2894–904. https://doi.org/10.1111/jog.15808.

Article  PubMed  CAS  Google Scholar 

Gaona-Luviano P, Medina-Gaona LA, Magaña-Pérez K. Epidemiology of ovarian cancer. Chinese Clin Oncol. 2020;9(4):47–47. https://doi.org/10.21037/cco-20-34.

Article  Google Scholar 

Liang X, Harris HR, Hendryx M, Shadyab AH, Hale L, Li Y, Crane TE, Cespedes Feliciano EM, Stefanick ML, Luo J. Sleep characteristics and risk of ovarian cancer among postmenopausal women. Cancer Prev Res. 2021;14(1):55–64. https://doi.org/10.1158/1940-6207.CAPR-20-0174.

Article  Google Scholar 

Gupta D, Lis CG. Role of CA125 in predicting ovarian cancer survival-a review of the epidemiological literature. J Ovarian Res. 2009;2:1–20. https://doi.org/10.1186/1757-2215-2-13.

Article  CAS  Google Scholar 

Zorn KK, Tian C, McGuire WP, Hoskins WJ, Markman M, Muggia FM, Rose PG, Ozols RF, Spriggs D, Armstrong DK. The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a gynecologic oncology group study. Cancer. 2009;115(5):1028–35. https://doi.org/10.1002/cncr.24084.

Article  PubMed  Google Scholar 

Morales-Vásquez F, Pedernera E, Reynaga-Obregón J, López-Basave HN, Gómora MJ, Carlón E, Cárdenas S, Silva-Ayala R, Almaraz M, Méndez C. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma. J Ovarian Res. 2016;9:1–6. https://doi.org/10.1186/s13048-016-0247-6.

Article  Google Scholar 

Guo N, Minas G, Synowsky SA, Dunne MR, Ahmed H, McShane R, Bhardwaj A, Donlon NE, Lorton C, O’Sullivan J, Reynolds JV, Caie PD, Shirran SL, Lynch AG, Stewart AJ, Arya S. Identification of plasma proteins associated with oesophageal cancer chemotherapeutic treatment outcomes using SWATH-MS. J Proteomics. 2022;266: 104684. https://doi.org/10.1016/j.jprot.2022.104684.

Article  PubMed  CAS  Google Scholar 

Noreen S, Akhtar S, Batool T, Gardner QA, Akhtar MW. Tubulin beta 2C Chain (TBB2C), a potential marker of ovarian cancer, an insight from ovarian cancer proteome profile. ACS Omega. 2021;6(16):10506–14. https://doi.org/10.1021/acsomega.0c03262.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tubio-Perez RA, Torres-Duran M, Fernandez-Villar A, Ruano-Ravina A. Alpha-1 antitrypsin deficiency and risk of lung cancer: a systematic review. Transl Oncol. 2021;14(1): 100914. https://doi.org/10.1016/j.tranon.2020.100914.

Article  PubMed  CAS  Google Scholar 

Hiller A-M, Ekström M, Piitulainen E, Lindberg A, Rönmark E, Tanash H. Cancer risk in severe alpha-1-antitrypsin deficiency. Europ Respirat J. 2022;60(4):2103200. https://doi.org/10.1183/13993003.03200-2021.

Article  CAS  Google Scholar 

Thompson S, Guthrie D, Turner G. Fucosylated forms of alpha-1-antitrypsin that predict unresponsiveness to chemotherapy in ovarian cancer. Br J Cancer. 1988;58(5):589–93. https://doi.org/10.1038/bjc.1988.265.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yip P, Chen T-H, Seshaiah P, Stephen LL, Michael-Ballard KL, Mapes JP, Mansfield BC, Bertenshaw GP. Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers. PLoS ONE. 2011;6(12): e29533. https://doi.org/10.1371/journal.pone.0029533.

Article  PubMed  PubMed Central  CAS  Google Scholar